Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
Immune checkpoint inhibitors have emerged as a novel therapeutic strategy for many different tumors, including clear cell renal cell carcinoma (ccRCC). However, these drugs are only effective in some ccRCC patients, and can produce a wide range of immune-related adverse reactions. Previous studies h...
Saved in:
Main Authors: | Jun Wang (Author), Weichao Tu (Author), Jianxin Qiu (Author), Dawei Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endoplasmic Reticulum Stress-Related Signature Predicts Prognosis and Drug Response in Clear Cell Renal Cell Carcinoma
by: Yuke Zhang, et al.
Published: (2022) -
A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma
by: Ming-Jie Lin, et al.
Published: (2023) -
High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
by: Wang X, et al.
Published: (2023) -
A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
by: Zhiyuan Li, et al.
Published: (2022) -
High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma
by: Yuting Tang, et al.
Published: (2022)